Arcadia Biosciences, Inc. (RKDA)Consumer Defensive | Packaged Foods | Dallas, United States | NasdaqCM
0.20 USD
-0.01
(-3.133%) ⇩
(Oct. 14, 2026, 4 p.m.
EDT)
After hours: 0.20 +0.00 (1.542%) ⇧ (Oct. 14, 2026, 7:58 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 8:52 a.m. EDT
The immediate outlook is severely clouded by a brutal technical breakdown and deteriorating corporate health. The stock has collapsed from a high of $5.72 to under $0.30, trading well below its 50-day and 200-day averages, indicating a massive trend reversal. Recent price action shows a sharp drop in late September followed by a lack of recovery, while the statistical forecast model leans negative for the coming month, albeit with low confidence. Fundamentally, the business is in distress with negative revenue growth, negative operating margins, and negative free cash flow. The company is raising capital through private placements and facing a reverse stock split vote, signaling liquidity concerns. There is no dividend to provide income, and the long-term trajectory over the last decade shows a catastrophic loss of over 99% of value, driven by eight consecutive years of declines. While the most recent annual anchor showed a temporary rebound, the underlying fundamentals of a company burning cash and shrinking revenues make this a high-risk speculative vehicle rather than an investment. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.089423 |
| AutoARIMA | 0.220943 |
| AutoETS | 0.221748 |
| MSTL | 0.222570 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 0.71 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.099 |
| Excess Kurtosis | 0.82 |
| Attribute | Value |
|---|---|
| Sector | Consumer Defensive |
| Revenue per Share | 2.428 |
| Market Cap | 484,251 |
| Forward P/E | -0.16 |
| Beta | 0.55 |
| Profit Margins | -234.53% |
| Website | https://arcadiabio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9599229 |
| Address1 | 5,956 Sherry Lane |
| Address2 | Suite 2000 |
| All Time High | 7,040.0 |
| All Time Low | 0.159 |
| Ask | 0.358 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 4,612,830 |
| Average Daily Volume3 Month | 1,318,607 |
| Average Volume | 1,318,607 |
| Average Volume10Days | 4,612,830 |
| Beta | 0.553 |
| Bid | 0.2101 |
| Bid Size | 1 |
| Book Value | 0.29 |
| City | Dallas |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.201 |
| Current Ratio | 3.487 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 0.2147 |
| Day Low | 0.1593 |
| Display Name | Arcadia Biosciences |
| Dividend Date | 1,516,752,000 |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,746,727,200 |
| Earnings Call Timestamp Start | 1,746,727,200 |
| Earnings Timestamp End | 1,773,954,000 |
| Earnings Timestamp Start | 1,773,954,000 |
| Ebitda | -3,792,000 |
| Ebitda Margins | -0.79899 |
| Enterprise To Ebitda | 0.974 |
| Enterprise To Revenue | -0.778 |
| Enterprise Value | -3,693,748 |
| Eps Forward | -1.28 |
| Eps Trailing Twelve Months | -4.55 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 530 756 7027 |
| Fifty Day Average | 0.45158 |
| Fifty Day Average Change | -0.25057998 |
| Fifty Day Average Change Percent | -0.5548961 |
| Fifty Two Week Change Percent | -95.992294 |
| Fifty Two Week High | 5.63 |
| Fifty Two Week High Change | -5.429 |
| Fifty Two Week High Change Percent | -0.96429837 |
| Fifty Two Week Low | 0.1593 |
| Fifty Two Week Low Change | 0.041700006 |
| Fifty Two Week Low Change Percent | 0.26177028 |
| Fifty Two Week Range | 0.1593 - 5.63 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,431,696,600,000 |
| Float Shares | 2,168,097 |
| Forward Eps | -1.28 |
| Forward P E | -0.15703125 |
| Free Cashflow | -868,500 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 8 |
| Fullday Change | 0.015500009 |
| Fullday Change Percent | 7.469884 |
| Fullday Price | 0.201 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.34598 |
| Gross Profits | 1,642,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.15867 |
| Held Percent Institutions | 0.18681999 |
| Implied Shares Outstanding | 2,409,211 |
| Industry | Packaged Foods |
| Industry Disp | Packaged Foods |
| Industry Key | packaged-foods |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,677,628,800 |
| Last Split Factor | 1:40 |
| Long Business Summary | Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas. |
| Long Name | Arcadia Biosciences, Inc. |
| Market | us_market |
| Market Cap | 484,251 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_10128457 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -11,131,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,026,323 |
| Open | 0.2026 |
| Operating Cashflow | -2,536,000 |
| Operating Margins | -0.34373 |
| Payout Ratio | 0.0 |
| Phone | 214 974 8921 |
| Post Market Change | 0.0030999929 |
| Post Market Change Percent | 1.542285 |
| Post Market Price | 0.2041 |
| Post Market Time | 1,792,022,282 |
| Previous Close | 0.2075 |
| Price Hint | 4 |
| Price To Book | 0.6931035 |
| Price To Sales Trailing12 Months | 0.1020335 |
| Profit Margins | -2.34534 |
| Quick Ratio | 2.878 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.00649999 |
| Regular Market Change Percent | -3.13253 |
| Regular Market Day High | 0.2147 |
| Regular Market Day Low | 0.1593 |
| Regular Market Day Range | 0.1593 - 0.2147 |
| Regular Market Open | 0.2026 |
| Regular Market Previous Close | 0.2075 |
| Regular Market Price | 0.201 |
| Regular Market Time | 1,792,008,000 |
| Regular Market Volume | 33,746,638 |
| Return On Assets | -0.34756002 |
| Return On Equity | -4.30933 |
| Revenue Growth | -0.008 |
| Revenue Per Share | 2.428 |
| Sand P52 Week Change | 0.1570785 |
| Sector | Consumer Defensive |
| Sector Disp | Consumer Defensive |
| Sector Key | consumer-defensive |
| Shares Outstanding | 2,409,211 |
| Shares Percent Shares Out | 0.0368 |
| Shares Short | 88,752 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 18,768 |
| Short Name | Arcadia Biosciences, Inc. |
| Short Percent Of Float | 0.0369 |
| Short Ratio | 0.04 |
| Source Interval | 15 |
| State | TX |
| Symbol | RKDA |
| Total Cash | 4,178,000 |
| Total Cash Per Share | 1.734 |
| Total Debt | 0 |
| Total Revenue | 4,746,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.55 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.15098 |
| Two Hundred Day Average Change | -0.94998 |
| Two Hundred Day Average Change Percent | -0.82536626 |
| Type Disp | Equity |
| Volume | 33,746,638 |
| Website | https://arcadiabio.com |
| Zip | 75,225 |